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To understand the normal and oncogenic functions of the protein-tyrosine kinase Abl, the yeast two-hybrid 
system has been used for identifying proteins that interact with it. One interacting protein is Crk-I, an 
SH3/SH2-containing adapter protein that was originally identified as the oncogenic element in the avian 
sarcoma virus CT10. Direct interaction between the Crk-I SH3 and Abl at novel, -10 amino acid sites just 
carboxy-terminal to the Abl kinase domain occurs in vitro and in mammalian cells. There is a nearby site 
specific for binding another adapter, Nck, and these sites also bind Grb-2. When bound to Abl, Crk-I was 
phosphorylated on tyrosine. Thus, the SH3-binding sites on Abl serve as substrate recognition sites for the 
relatively nonspecific kinase of Abl. In Crk-I-transformed cells, Crk-I associates with endogenous c-Abl and is 
phosphorylated on tyrosine. The association of Crk and Abl suggests that Abl could play a role in v-Crk and 
Crk-I transformation and that normal Abl function may be partly mediated through bound adapter molecules. 
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The ab/oncogene was first identified as the oncogenic 
element in the Abelson murine leukemia virus (for re- 
view, see Rosenberg and Witte 1988; Wang 1993). It is 
also an oncogenic element in the Philadelphia chromo- 
some, a fusion of a portion of the breakpoint cluster e- 
gion (bcr) gene with c-abl found first in cells of human 
chronic myelogenous leukemia (for review, see Daley 
and Ben-Neriah 1991). 
Although all cells contain some c-Abl, the protein may 
play a particular ole in certain developmental events. 
Drosophila Abl mutants have a disrupted axonal organi- 
zation and die in the pupal stage of development (Hen- 
kemeyer et al. 1990). Mice with a homozygous disrup- 
tion of the c-abl gene--either through a null mutation or 
a deletion of the carboxy-terminal '/3of the protein--are 
variably affected, but some display increased perinatal 
mortality, runtedness, lymphopenia, nd abnormal head 
and eye development (Schwartzberg et al. 1991; Ty- 
bulewicz et al. 1991). 
The amino-terminal half of c-Abl is similar to that of 
many Src family kinases in which Src homology regions 
SH3 and SH2 abut the kinase (Pawson 1988). SH2 and 
SH3 domains are modular units present in a very large 
group of proteins (for review, see Mayer and Baltimore 
1993; Pawson and Gish 1992). SH2s, -100 amino acids 
long, bind to short peptide segments containing a phos- 
phorylated tyrosine residue. Frequently, SH2 binding 
~Corresponding author. 
links activated growth factor receptors to downstream 
signal transduction proteins (Pawson and Gish 1992). 
SH3 domains contain -50-60 amino acids and mediate 
protein-protein i teractions among signal transduction 
proteins by binding to proline-containing sites (Cicchetti 
et al. 1992; Egan et al. 1993; Gout et al. 1993; Li et al. 
1993; Liu et al. 1993; Ren et al. 1993; Rozakis-Adcock et 
al. 1993; Weng et al. 19931. 
Although c-Abl is largely nuclear, some is associated 
with the plasma membrane or with actin filaments (Van 
Etten et al. 1989, 1993; McWhirter and Wang 19911. It is 
different from most tyrosine kinases in having a long 
carboxyl terminus that is encoded by a single long exon. 
In this region of >600 amino acids, there is a DNA- 
binding domain, an actin-binding domain, and a nuclear 
localization signal (Jackson and Baltimore 1989; Van Et- 
ten et al. 1989; Wang 1993). The complexity of c-Abl 
structure and localization in cells suggests that it may 
either fulfill multiple cellular functions or that it inte- 
grates multiple events. Overproduction ofc-Abl does not 
result in cell transformation or elevated tyrosine phos- 
phorylation in cells, suggesting that the c-Abl protein- 
tyrosine kinase activity is tightly controlled in vivo 
(Franz et al. 1989; Jackson and Baltimore 1989). Instead, 
overproduction leads to inhibition of cell growth during 
G1, suggesting that c-Abl can interact with the machin- 
ery of cellular growth control (Jackson et al. 1993a). In 
contrast to c-Abl, transforming variants of Abl are 
largely cytoplasmic and their kinase activity is constitu- 
tively activated (Franz et al. 1989; Jackson and Baltimore 
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1989; Van Etten et al. 1989; Jackson et al. 1993b; Muller 
et al. 1991; Goga et al. 1993). 
One way to develop a better understanding of the nor- 
mal and oncogenic functions of Abl is to look for pro- 
teins that regulate c-Abl or are regulated by it. In this 
study the entire carboxy-terminal halfof Abl was used as 
a bait to screen a HeLa cDNA expression library using 
the yeast wo-hybrid system (Fields and Song 1989; Zer- 
vos et al. 1993). One clone isolated was a fragment of the 
Crk-I protein, an SH2- and SH3-containing adapter that 
was originally identified as the oncogenic element of 
avian sarcoma virus CT10 (Mayer et al. 1988). Crk-I and 
Abl interaction occurs in vitro and in mammalian cells 
and, when bound to Abl, Crk-I is phosphorylated on ty- 
rosine. Binding is a consequence of short, linear peptide 
sequences in Abl that bind to SH3 regions of Crk. A site 
for binding the SH3-containing Nck molecule was also 
found. These studies show that SH3 can be a binding 
region for a kinase substrate, extend our knowledge of 
SH3 binding-specificity, suggest that Abl may play a role 
in Crk transformation, and that c-Abl may use adapter 
molecules in its normal function. 
Resu l ts  
Proteins that interact with the Abl carboxy-terminal 
region 
A yeast wo-hybrid system was used to identify proteins 
that interact with c-Abl. The two-hybrid system, origi- 
nally described by Fields and Song (1989), depends on a 
transcriptionally derived signal for identification of a 
gene encoding a protein that interacts with a protein of 
interest. One hybrid consists of a DNA-binding domain 
fused to the protein of interest, and the other consists of 
a transcriptional ctivation domain fused to a cDNA li- 
brary. The two-hybrid system used in this study was 
developed by R. Brent and colleagues (Zervos et al. 1993). 
For identifying proteins that interact with the carboxy- 
terminal half of c-Abl (AblC'), a cDNA fragment encod- 
ing amino acids 545-1149 of c-Abl was cloned in-frame 
into the pEG202 vector so it would be made as a fusion 
protein with the LexA DNA-binding domain (LexA/ 
AblC'). The LexA/AblC'-encoding plasmid was trans- 
formed into yeast EGY48 along with a reporter plasmid 
that contains the B-galactosidase g ne under LexA-oper- 
ator control, LexAop-lacZ; the yeast genome also con- 
tained an integrated LexAop-LEU2 reporter gene. The 
expression of the LexA/AblC' fusion protein was con- 
firmed by Western blot analysis using PEX4 anti-Abl an- 
tibody [data not shown). Although the yeast contained 
LexA-controlled genes for synthesis of B-galactosidase 
and the LE U2 protein, neither gene was expressed, indi- 
cating that the AblC' region provided no transcriptional 
activating activity. 
To identify proteins that interact with AblC', we used 
a HeLa cDNA library cloned into a conditional expres- 
sion vector pJG45. In the presence of galactose but not 
glucose, this vector produce cDNA-encoded proteins 
fused to an epitope tag, a nuclear localization sequence, 
and an acidic transcription activation domain. Five mil- 
lion library transformants were plated onto five galac- 
tose-Leu- selection plates. Colonies that were pro- 
totrophic for leucine were replica-plated onto X-gal 
plates, where ~-galactosidase-producing olonies turn 
blue. About 100 galactose-dependent, blue colonies were 
picked, of which 10 were analyzed further in this study. 
These clones represent -500,000 library transformants 
screened. 
The 10 library cDNA plasmids were isolated through 
genetic selection in Escherichia coli. To test whether the 
library cDNAs truly encoded proteins that interacted 
specifically with AblC', the library plasmids were 
cotransformed back into yeast with vectors that pro- 
duced either the LexA-binding domain alone or the bind- 
ing domain fused to the entire c-Abl or AblC'. Nine of 
the clones produced ~-gal activity only when c-Abl or 
AblC' was present (Table 1), suggesting that these 
cDNAs encode proteins that interact with the carboxy- 
terminal half of c-Abl. The remaining one clone was ac- 
tive even when cotransformed with the LexA DNA- 
binding domain alone, indicating that this clone did not 
encode a c-Abl-interacting protein. 
Crk cDNA identified 
DNA sequence analysis revealed that the nine c-Abl- 
interacting clones identified by the two-hybrid screen 
belonged to three genes. The DNA sequences were com- 
pared with sequences from GenBank. Two of them 
(clone A, representing six independent clones, and clone 
C) were found to be novel genes. The DNA sequence of 
clone B, representing 2 of 10 primary clones, was iden- 
tical to part of the human proto-oncogene Crk-I cDNA 
{Fig. 1). 
The Crk oncogene was originally isolated as the onco- 
genic element of avian retrovirus CT10 [Mayer et al. 
1988] and ASV-1 (Tsuchie et al. 1989). The human c-Crk 
proto-oncogene encodes two proteins, Crk-I and Crk-II, 
through altemative splicing pathways (Matsuda et al. 
1992). Crk-I and Crk-II proteins are adapter molecules 
containing primarily SH2 and SH3 domains: Crk-II has 
one SH2 and two SH3 domains; Crk-I lacks the carboxy- 
Tab le  1. Clones interacting with carboxy-terminal portion 
of Abl in yeast two-hybrid system 
~-Gal activity in yeast  a 
Frequency with with 
{in 5 x l0 s pEG202/  pEG202/ with 
Clone transformantsl AblC' Abl pEG202 
A 6 + + - 
B 2 + + - 
C 1 + + - 
D 1 + + + 
a~-Gal activity in yeast was detected in X-gal plates. Entries 
indicate the presence or absence of blue color with transfor- 
mants. 
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CRK-II 
SH2 N-SH3 C-SH3 
1 ~  04 
CRK-I 1 ~  204 
88 
C lone-B  ~ ~ ~ V ~ 1 2 0 4  
Figure 1. Schematic representation f the c-Abl-interacting 
Crk protein identified by genetic screening. The domain struc- 
tures of human Crk-I and Crk-II (Matsuda et al. 1992) are com- 
pared with the primary structure of clone B found to interact in 
the two-hybrid screen with Abl. 
terminal SH3 domain. The Abl-interacting clone B 
cDNA lack the sequence ncoding the amino-terminal 
87 amino acids of Crk-I cDNA, thus producing apartial 
Crk-I protein from which the SH2 domain was mostly 
deleted (Fig. 1). The Crk/Abl interaction therefore ap- 
peared to be mediated by the Crk-I SH3 domain (CrkI- 
SH3). 
CrkI-SH3 binds c-AbI in vitro 
To examine whether CrkI-SH3 bound Abl directly, an in 
vitro filter assay was employed. For this assay, the 
cloned partial Crk-I protein was expressed as a glutathi- 
one S-transferase fusion protein in E. coli (referred as 
GST/CrkI-SH3). GST/CrkI-SH3 was purified using glu- 
tathione-agarose beads, biotinylated as described (Mayer 
et al. 19911, and used as a probe on filters containing Abl 
protein. 
The cDNA encoding AblC' was expressed in E. coli by 
cloning it in-frame carboxy-terminal to GST. Crk bind- 
ing to the GST/AblC' fusion protein was examined fol- 
lowing electrophoretic fractionation of crude E. coli ex- 
tracts, transfer to a filter, and probing with biotinylated 
GST/CrkI-SH3. As revealed by anti-GST antibody (Fig. 
2) and PEX4 anti-Abl antibody (data not shown), the 
GST/AblC' fusion protein expressed in bacteria had an 
apparent molecular mass of 110 kD. However, the ma- 
jority of the GST/AblC' fusion protein was degraded into 
polypeptides with various sizes. Because AblC' was 
tagged with GST, this natural degradation ofGST/AblC' 
facilitated mapping of the binding sites for Crk and other 
SH3-containing proteins. 
The GST/CrkI-SH3 probe bound to the full-length 
GST/AblC' fusion protein and to a number of its degra- 
dation products (Fig. 2). Binding of the GST/CrkI-SH3 
probe to GST and the GST probe to the GST/AblC' fu- 
sion protein was not detected, indicating that the inter- 
action of GST/CrkI-SH3 and GST/AblC' was through 
the binding of CrkI-SH3 to AblC'. The GST/AblC' deg- 
radation products that bound to CrkI-SH3 were similar 
to those bound to anti-GST antibody, suggesting that the 
CrkI-SH3-binding site is located in the amino-terminal 
portion of AblC'. 
216 --- 
105~ 
70~ 
43~ 
28--" 
CRK1 Grb2 Nck Abi Sr¢ N-Src GST Anti- 
SH3 SH3 SH3 SH3 GST 
AS  A~'A"~"  AB AB AB AS  AS  
Figure 2. In vitro binding ofthe c-Abl carboxy-terminal half to 
various SH3 domains and SH3-containing proteins. Proteins 
from induced lysates of bacteria that expressed the GST-AblC' 
fusion protein (A) or GST (B) were probed with anti-GST anti- 
body or with biotinylated GST or GST fusion proteins a indi- 
cated above each pair of lanes. Numbers (left) represent the 
molecular size in kilodaltons. 
The CrkI-SH3 probe used to examine the Crk-Abl in- 
teraction in vitro contained flanking sequences of the 
SH3 domain. To confirm that the Crk-Abl interaction 
was through the Crk-I SH3 domain alone, the first SH3 
domain of murine c-Crk (Cicchetti et al. 1992) was 
tested for binding to AblC'. The murine Crk SH3 bound 
to AblC' as effectively as did CrkI-SH3 (data not shown). 
Both the murine Crk SH3 domain and cloned human 
CrkI-SH3 could also bind overexpressed full-length 
c-Abl from NIH-3T3 cells (data not shown). 
CrkI-SH3-binding sites are in a region 
between the Abl kinase domain and its nuclear 
localization signal 
The pattern of CrkI-SH3 binding to the degradation 
products of the GST/AblC' fusion protein suggested that 
the SH3-binding site was located in the amino-terminal 
region of AblC'. Sequential deletion analysis of AblC' 
from its carboxyl terminus mapped the CrkI-SH3-bind- 
ing site to a 56-amino-acid region (Table 2). In this region 
there are three proline-containing peptides (APELPT- 
KTR, EPAVSPLLPRK, and APDTPELLHTK) that drew 
Table 2. Mapping of the Crk, Nck, and Grb2 
SH3-binding sites 
SH3 binding a 
GST fusion peptides CrkI-SH3 Nck Grb2 
AblC' (545-1149} b + + + 
AblC'•Sal (545-987) + + + 
AblC'aXho (545-763) + + + 
AblC'115 (545-659) + + + 
AblC'56 (551-606) + - + 
aDetermined by filter-binding assay. 
bNumbers indicate the amino acid sequences in type IV c-Abl. 
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our attention because other SH3s bind to sites rich in 
proline (Ren et al. 1993). The binding sites for the CrkI- 
SH3 domain were determined by preparing GST fusions 
of these peptides and expressing them in bacteria. Filter- 
binding assays howed that CrkI-SH3 bound strongly to 
peptide APELPTKTR and weakly to peptide EPAVSPLL- 
PRK (Fig. 3A). These two peptides are termed Abl-bind- 
ing sites for SH3 (AB3-1 and AB3-2). No binding to a 
third peptide, APDTPELLHTK, was detected (data not 
shown). Deletion of the two CrkI-SH3-binding sites 
abolished the association between Crk-I and c-Abl in 
cells {see below}, indicating that in Abl there are two 
CrkI-SH3 binding sites located between the Abl kinase 
domain and the nuclear localization signal (Fig. 3B). 
SH2- and SH3-containing adapter proteins Grb2 
and Nck bind to Abl in vitro 
To examine the specificity of Crk-Abl interaction, the 
binding potential of different SH3 domains or SH3-con- 
taining proteins to Abl was tested by the filter-binding 
assay. The Abl-SH3 and Src-SH3 domains bound to 
GST/AblC' very weakly, but above the signal of GST 
alone (Fig. 2). No binding was detected for neural-Src 
(N-Src). According to the binding pattern to the degrada- 
tion products of GST/AblC', the binding site for Abl- 
SH3 seems to be located carboxy-terminal to the Crk and 
Nck SH3-binding sites. This low affinity interaction 
may be significant for intramolecular interaction and 
may play a role in the control Abl kinase activity and/or 
autophosphorylation. 
Interestingly, both of the SH2- and SH3-containing 
adapter proteins, Grb2 and Nck, bound to AblC' as 
strongly as did CrkI-SH3 (Fig. 2). The pattem of Grb2 
binding to GST/AblC' and its degradation products was 
similar to that of CrkI-SH3, suggesting that Grb2-bind- 
ing sites are located very close to those of CrkI-SH3. 
However, Nck bound only to the larger degradation prod- 
ucts of GST/AblC', indicating that Nck binds in a region 
carboxy-terminal to the CrkI-SH3 sites. 
We mapped the Nck-binding site to a 53-amino-acid 
region (606-659) (Table 2). The ability of Nck to bind the 
proline-containing peptide MAPTPPKR (AB3-3) in this 
region, expressed as a GST fusion protein in bacteria, 
was tested by the filter-binding assay. Nck bound AB3-3 
specifically, but in spite of the three SH3 domains in 
Nck, no binding of Nck to AB3-1 and AB3-2 was detected 
(Fig. 3A). CrkI-SH3 bound very weakly to AB3-3. 
Binding of Grb2 to the three AB3s was also examined. 
Grb2 bound to AB3-1 and AB3-3 strongly and to AB3-2 
weakly (Fig. 3A). Because Grb2 contains two SH3 do- 
mains, the binding of different SH3 domains of Grb2 to 
AB3s was determined using Grb2 mutants. Grb2-N2 is 
Grb2 with the carboxy-terminal SH3 domain deleted. 
Grb2-2C is Grb2 with the amino-terminal SH3 domain 
deleted (Lowenstein et al. 1992}. Grb2-N2 bound all 
A C 
GST FUSION PROTEIN 
PROBES AntI-GST 
CRK1 
SH3 Nck Grb2 Grb2-N2 Grb2-2C 
(3<<< t3<<<[  (3<<< (3<[<< (3<<< (3<<< 
S i tes  Sequences  SH3 ' s 
3BP1-10  A P T H P P L P Abl 
3BP2-9  f P A Y P P P V Abl 
AB3-1  A E L T K T R Crk,  Grb2  
AB3-2 E P A V S L L R K Crk,  Grb2 
AB3-3  M A T P K R Nck,  Grb2  
B 
MYR 
N C 
~ ~ G~ ~" ~- LL~ t I~t-~,~'~'~,~-~-~-~-~,~'~t I 
AB3-1 AB3-2 AB3-3 
551APELPTKTR559 5S0EPAVSPLLPRK601 636MAPTPPKR643 
Binding Crk (N-SH3) Crk (N-SH3) Nck 
Protein Grb2 (N- and CoSH3) Grb2 (N-SH3) Grb2 (N-SH3) 
pXXP 
Figure 3. Mapping of the Crk, Nck, and Grb2 SH3-binding 
sites on c-Abl. (A) Proteins from induced lysates of bacteria 
expressing the GST fusion peptides (AB3s) were probed with 
anti-GST antibody or biotinylated GST fusion proteins as 
indicated. (B) Schematic representation f the domain struc- 
ture of c-Abl type W. The amino acid sequences of theCrk, 
Nck, and Grb2 SH3-binding s tes and their locations in c-Abl 
are indicated. Amino acid residues are represented by single 
letters. {MYR) Myristoylation site; (NLS) nuclear localiza- 
tion signal; (BD) binding domain. Numbers indicate the po- 
sitions of amino acids in type IV c-Abl (Ben-Neriah et al. 
1986). [C} An alignment of the Abl, Crk, Nck, and Grb2 
SH3-binding sites. (e} The amino acid residues sential for 
the Abl-SH3-binding to 3BP1-10 (Ren et al. 1993). (X in con- 
sensus) The nonconserved amino acids among SH3-binding 
sites. 
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three AB3s: AB3-3 was strongest and AB3-2 weakest (Fig. 
3A). The binding of Grb2-N2 to AB3-1 was weaker than 
that of wild-type Grb2. Grb2-2C bound weakly and only 
to AB3-1. The different specificities of the two SH3 do- 
mains of Grb2 suggested that they may bind Abl coop- 
eratively in a specific orientation. 
The locations of the CrkI-SH3, Grb2, and Nck-binding 
sites in c-Abl are shown in Figure 3B. 
Two proteins that bind specifically to the Abl-SH3 
domain were isolated previously by screening a hgtll 
cDNA expression library using the GST/Abl-SH3 fusion 
protein (Cicchetti et al. 1992). The SH3-binding sites of 
the two SH3-binding proteins were localized to a 10- 
amino-acid stretch very rich in proline residues (Ren et 
al. 1993). In the 3BP1 site, proline residues at positions 2, 
7, and 10, were crucial to the binding. A number of SH3- 
binding proteins have been identified since then (Egan et 
al. 1993; Gout et al. 1993; Li et al. 1993; Liu et al. 1993; 
Rozakis-Adcock et al. 1993; G. Cheng, S.-Z. Ye, and D. 
Baltimore, in prep.; K. Alexandropoulos and D. Balti- 
more, unpubl.). All of the SH3-binding sites have been 
characterized by multiple proline residues. Although the 
Abl-SH3- and CrkI-SH3-binding sites are very different 
in amino acid sequence, they can be aligned with two 
conserved proline residues paced by two nonconserved 
amino acids (Fig. 3C). The Crk, Nck, and Grb2 SH3- 
binding sites share basic amino acids at heir carboxyl 
terminus not found in the Abl sites. 
Crk-I associates with both c-Abl and transforming 
Abl in mammaBan cells 
The studies described above demonstrated that trun- 
cated Crk, consisting of the SH3 domain and its flanking 
sequences, interacts with c-Abl both in yeast and in 
vitro. To determine whether Crk associates with Abl in 
vivo, full-length uman Crk-I cDNA was cloned by re- 
verse transcriptase (RT)-PCR. For identification pur- 
poses, the Crk-I protein was tagged with an influenza 
virus hemagglutinin (HA) epitope at its amino terminus, 
producing the HACrkI chimera. The gene for this chi- 
meric protein was subcloned into mammalian expres- 
sion vector pGD, in which the Moloney leukemia viral 
long terminal repeat (LTR) directs RNA synthesis. 
To study the interaction of Crk and Abl in cells, we 
first examined a transforming allele of Abl. Human kid- 
ney 293 cells were either cotransfected with pGD/ 
HACrkI and pGD/c-abMXB, which encodes SH3-de- 
leted transforming Abl, or transfected with PGD/c- 
abMXB alone. Mter 48 hr the cells were lysed and the 
lysates were immunoprecipitated with either anti-HA 
monoclonal antibody (12CA-5), the anti-AN polyclonal 
antibody PEX4, or control antibodies. The immunopre- 
cipitates were then subjected to an in vitro kinase assay, 
using [~/-Pa2]ATP to label proteins in vitro. Labeled pro- 
teins were separated electrophoretically b SDS-PAGE 
and detected by autoradiography. A 140-kD phosphory- 
lated protein was precipitated by anti-HA antibody, but 
not control monoclonal antibody, from cells cotrans- 
fected with pGD/HACrkI and pGD/c-ablAXB (Fig. 4A). 
This 140 kD protein comigrated with AblAXB, as de- 
tected by anti-Abl antibody PEX4 (Fig. 4A). AblAXB was 
not precipitated by anti-HA antibody from cells trans- 
fected with either pGD/HACrkI {data not shown) or 
pGD/c-ablAXB alone. Thus the antibody to HACrkI co- 
precipitated the Abl protein as detected by its autophos- 
phorylation activity. 
A phosphorylated 28-kD protein was precipitated by 
both anti-HA antibody and anti-Abl antibody, but not 
control antibody, from cells cotransfected with pGD/ 
HACrkI and pGD/c-ablAXB but not from cells trans- 
letted with pGD/c-abMXB alone (Fig. 4A). This 28-kD 
protein migrated identically to tyrosine-phosphorylated 
Crk-I protein as detected by Western blot using anti-HA 
antibody (data not shown), a~p Incorporation into 
HACrkI was much less following precipitation by anti- 
HA antibody than by anti-Abl antibody. This may be 
attributable to a blocking effect of the bound anti-HA 
antibody. 
To determine whether Crk interacts with c-Abl, hu- 
A 
216- -  
105- -  
70- -  
43, -  
28 - -  
~- O. 0. Z B 
I 
c.ablAXB+ 
HACRK1 
216 - -  
105--. 
70- -  
43,,.- 
28.-- 
I I  i I I I  
c-abhU(B c.ab~ 
HACRK1 
Q. D. 
I 
c.abPm2+ 
HACRK1 
Figure 4. Intracellular association of Crk-I and Abl. (A) 
Immunoprecipitation (IP} and in vitro kinase analysis of 
293 cells expressing the transforming c-Abl~kXB or 
c-Abl~XB plus HACrkI. (B) IP kinase analysis of 293 cells 
expressing c-Abl plus HACrkI or c-Abl m"2 plus HACrkI. 
IP antibodies are indicated over the lanes. {12CA5) Anti- 
HA antibody (IgG2b); (-Mab) anti-RAG2 monoclonal an- 
tibody (IgG2b) as a control; (PEX4) anti-Abl antibody; 
(NRS) normal rabbit serum. Gels were exposed to X-ray 
film overnight. The positions of Abl tyrosine kinase and 
phosphorylated HACrkI protein on the gels are indicated 
(right). Numbers (left) represent the molecular size in 
kilodaltons. 
GENES & DEVELOPMENT 787 
 Cold Spring Harbor Laboratory Press on April 23, 2020 - Published by genesdev.cshlp.orgDownloaded from 
Ren et al. 
man kidney 293 cells were cotransfected with pGD/ 
HACrkI and pGD/c-abI, and 32P-labeled, immunopre- 
cipitated proteins were detected after phosphorylation in 
vitro. As with transforming Abl, labeled Crk-I and c-Abl 
were specifically precipitated by both anti-HA and anti- 
Abl antibody [Fig. 4B), indicating that Crk-I associates 
with c-Abl in cells. 
The SH3-binding sites on Abl are needed for Crk 
interaction in cells 
The in vitro studies mapped the Crk SH3-binding site on 
Abl to a region between the Abl kinase domain and its 
nuclear localization signal. To determine whether the 
association of Crk and Abl in vivo was directly mediated 
by this interaction, the CrkI-SH3-binding sites were mu- 
tated in c-Abl by deletion. Mutation of the higher affin- 
ity CrkI-SH3 binding site, AB3-1, gave the c-Abl mul mu- 
tant Abl protein. Mutation of both CrkI-SH3-binding 
sites, AB3-1 and AB3-2, gave c-Abl mu2 mutant Abl pro- 
tein. The expression and in vitro kinase activity of the 
mutant Abl proteins were similar to that of c-Abl (Fig. 
4B). To examine whether HACrkI interacts with the mu- 
tant Abl proteins, they were coexpressed in 293 cells. 
Immunoprecipitation a d in vitro kinase assay showed 
that HACrkI and c-Abl r"ul still form a complex in cells 
(data not shown). Association of HACrkI and c-Abl mu2 
however, was not detected by immunoprecipitation and 
kinase assay (Fig. 4B), indicating that Crk-I interacts 
with Abl through the CrkI-SH3 domain's binding to the 
defined sites in Abl. 
Crk is phosphorylated on tyrosine upon binding to Abl 
The immunoprecipitation studies showed that Crk-I 
protein and Abl were coprecipitated by both anti-HA an- 
tibody and anti-Abl antibody. The Crk-I protein was 
phosphorylated asshown by 32p incorporation, suggest- 
ing that Crk-I is an Abl kinase substrate. To examine 
whether Crk-I is phosphorylated byAbl kinase in vivo, 
293 cells were either transfected with pGD/HACrkI or 
cotransfected with pGD/HACrkl and pGD/c-abl. After 
48 hr, cells were metabolically labeled with 32P i. 32P i- 
labeled ceils were then lysed, and the lysates were sub- 
jected to immunoprecipitation with anti-HA monoclo- 
hal antibody. The immunoprecipitates were separated 
electrophoretically b  SDS-PAGE and detected by auto- 
radiography. In cells overexpressing HACrkI alone, it 
was very weakly phosphorylated and migrated with an 
apparent molecular mass of 24 kD [Fig. 5A). In cells co- 
expressing HACrkI and c-Abl, HACrkI was hyperphos- 
phorylated and its electrophoretic mobility was quanti- 
tatively shifted to an apparent molecular mass of 28 kD 
[Fig. 5A). Autophosphorylation f c-Abl in cells was not 
detectable. Phosphoamino acid analysis demonstrated 
that the hyperphosphorylated HACrkI contained mainly 
phosphotyrosine and some phosphoserine (Fig. 5B). The 
phosphoamino acidIs) in the 24-kD HACrkI from ceils 
not transfected with c-Abl could not be detected under 
this condition. 
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Figure 5. HACrk-I is phosphorylated on tyrosine by c-Abl. (A) 
Immunoprecipitation f the 32p-labeled 293 cells expressing 
HACrkI (lane 1), c-Abl {lane 2), and HACrkI plus c-Abl {lane 3) 
with anti-HA antibody. The top and bottom autoradiograph rep- 
resent short and long exposures of the gel. Positions ofmolec- 
ular size markers of 216, 105, 70, 43, 28, and 18 kD are marked 
at left from top to bottom, respectively. (B I Phosphoamino acid 
analysis of HACrkI immunoprecipitated from 293 cells express- 
ing HACrkI plus c-Abl. Positions of the P-Ser, P-Thr, and P-Tyr 
phosphoamino acid standards are indicated. Arrows indicate in- 
completely hydrolyzed phosphopeptides. (Off) Origin of the 
spotted sample. (C) Western blot analysis with anti-HA anti- 
body of the anti-HA immunoprecipitates from 293 cells ex- 
pressing HACrkI (lanes 1,3) and HACrkI plus c-Abl (lanes 2,4) in 
the presence (lanes 1,2) or absence (lane 3,4) of sodium othor- 
vanadate. The blot was developed with HRP-conjugated goat 
anti-mouse IgG2b and enhanced chemiluminescence (ECL, Am- 
ersham I. 
To examine whether the slower migration rate of the 
hyperphosphorylated HACrkI was attributable ntirely 
to its tyrosine phosphorylation, cells expressing HACrkI 
or HACrkI plus c-Abl were lysed and immunoprecipi- 
tated with anti-HA antibody in the presence or absence 
of sodium orthovanadate, a compound that was included 
in all of the analyses described previously to inhibit en- 
dogenous tyrosine-specific phosphatases. The immuno- 
precipitates were then subjected to Western blot analysis 
with anti-HA antibody. In the presence of vanadate, the 
HACrkI protein from cells coexpressing HACrkI and 
c-Abl migrated more slowly than it did in the absence of 
c-Abl {Fig. 5C, lanes 1,2}. In the absence of vanadate, the 
HACrkI protein migrated similarly whether derived 
from cells expressing HACrkI alone or HACrkI and c-Abl 
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(lanes 3,4). Only the slower migrating HACrkI contained 
phosphotyrosine, as detected by antiphosphotyrosine a - 
tibody {data not shown). These data indicate that the 
Abl-generated electrophoretic mobility shift of HACrkI 
in SDS-PAGE is attributable to tyrosine phosphoryla- 
tion. 
Using the mutants of c-Abl described above, we could 
show that the phosphorylation of Crk depended on its 
ability to interact with Abl. Compared with wild type 
{Fig. 6, lane 2), less HACrkI protein was tyrosine phos- 
phorylated in cells coexpressing HACrkI and c-Abl r"ul 
(lane 3) and very little phosphorylated form was evident 
when both CrkI-SH3-binding sites were deleted in 
c-Abl mu2 {lane 4). The expression of c-Abl and mutant 
c-Abl proteins in these cells was about equal (data not 
shown), directly demonstrating that the HACrk/Abl 
SH3-mediated interaction makes HACrk a substrate for 
the Abl kinase domain. 
Crk-I associates with c-Abl and is phosphorylated 
in Crk-I-transformed fibroblast cells 
Chicken embryo fibroblasts infected with the avian ret- 
rovirus CT10 become rapidly transformed in tissue cul- 
ture (Mayer et al. 1988). Cells transformed by CT10 virus 
display elevated tyrosine phosphorylation o  a number 
of proteins (Matsuda et al. 1990; Mayer and Hanafusa 
1990a), suggesting that there is a tyrosine kinase in- 
volved in v-Crk transformation. Overexpression of hu- 
man Crk-I, but not Crk-II, leads to transformation of
mammalian fibroblasts (Matsuda et al. 1992). To exam- 
ine whether the endogenous c-Abl is a Crk-I-associated 
tyrosine kinase in Crk-I-transformed cells, we estab- 
lished an HACrkI-transformed NIH-3T3 cell line (see 
Materials and methods). In the HACrkI-transformed 
cells, HACrkI induces and associates with a number of 
tyrosine phosphorylated proteins typically seen in v-Crk 
and Crk-I-transformed cells {data not shown; Matsuda et 
al. 1992). Western blot analysis using anti-Abl monoclo- 
nal antibody showed that c-Abl was precipitated by anti- 
HA antibody from a transformed cell line (Fig. 7A, lane 1) 
but not by an isotype-matched control monoclonal anti- 
body {lane 3). Anti-Abl rabbit antibody PEX4 precipitated 
more Abl (lane 4), and normal rabbit serum did not pre- 
cipitate the protein {lane 2). Precipitation of Abl by anti- 
HA antibody was seen in an i dependent transformed 
line (data not shown). 
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Figure 6. Western blot analysis with anti-HA antibody of the 
293 cells expressing HACrkI (lane 1), HACrkI plus c-Abl (lane 
2), HACrkI plus c-Abl mul (lane 3), and HACrkI plus c-Abl mu2 
(lane 4). Arrows indicate positions of tyrosine-phosphorylated 
and non-tyrosine-phosphorylated HACrkI proteins on filter. De- 
veloped with HRP-conjugated goat anti-mouse IgG2b and ECL. 
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Figure 7. Association of HACrkI with Abl and phosphoryla- 
tion of HACrkI in the HACrkI-transformed cells. (A) The 
HACrkI-transformed cell lysates were immunoprecipitated 
with antibodies indicated over the lanes (see Fig. 4A). The im- 
munoprecipitates were subjected to Western blot analysis with 
anti-Abl monoclonal ntibody and developed with HRP-conju- 
gated goat nti-mouse IgG and ECL. Arrow indicates the posi- 
tion of the Abl tyrosine kinase; the bracket indicates immuno- 
globulin heavy chain on the blot. Numbers (left} represent the 
molecular size in kilodaltons. (B). Western blot analysis with 
anti-HA antibody of the 293 cells expressing HACrkI {lane I), 
HACrkI plus c-Abl (lane 2), and HACrkI-transformed NIH-3T3 
ceils (lane 3). Arrows indicate positions of tyrosine-phosphory- 
lated and non-tyrosine-phosphorylated HACrkI proteins on fil- 
ter. Developed with HRP-conjugated goat an i-mouse IgG2b and 
ECL. 
In 293 cells transfected with both HACrkI and Abl, we 
showed that HACrkI is phosphorylated on tyrosine 
when it can bind to Abl. The phosphorylated HACrkI 
migrates more slowly than the unphosphorylated form 
on SDS-PAGE. In HACrkI-transformed cells, the electro- 
phoretic mobility of a portion of HACrkI was shifted to 
this higher apparent molecular weight (Fig. 7B, lane 3), 
and this form reacted with antiphosphotyrosine anti- 
body (data not shown). Thus, in Crk-I-transformed cells 
a portion of Crk-I associates with endogenous c-Abl and 
is phosphorylated on tyrosine. 
Discussion 
Using the yeast two-hybrid screen, in vitro binding as- 
says, and interaction assays in mammalian cells, we 
have found that Abl contains elective binding sites for 
SH3 domains of Crk and Nck. The binding sites for Crk 
can mediate HACrk phosphorylation, implying that they 
serve the function of substrate binding sites. This work 
demonstrates that SH3 domains are versatile units for 
bringing together cellular proteins in a highly specific 
manner, that SH3 units can serve as substrate binding 
sites for enzymes, that Abl [unction must involve previ- 
ously unsuspected interactions with adapter proteins, 
and that Crk may function at least partly through Abl. 
We reported previously that SH3 domains can bind 
with high affinity to target proteins using as binding 
sites small, linear, proline-rich determinants (Ren et al. 
1993). The present study extends that concept by show- 
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ing that many SH3s have binding sites, each with a dif- 
ferent specificity not necessarily involving more than 
two prolines. Thus, SH3 domains can provide the spec- 
ificity to mediate aggregation of many highly specific 
protein complexes. Studies of the interaction of SH3 do- 
mains on Grb2 with proline-rich sites on Sos protein 
have also extended the range of action of SH3 regions 
(ref. in McCormick 1993). There, it appears that the 
function of SH3 is to bring the Sos protein to the cell 
membrane where it can find its substrate Ras. Similarly, 
SH3 domains were implicated in directing cellular local- 
ization of PLC7 and Grb2 (Bar-Sagi et al. 1993). The GT- 
Pase dynamin binds to and is activated by SH3 domains 
on other proteins {Gout et aI. 1993). Furthermore, we 
have found recently that SH3 domains on Fyn, Lyn, and 
Hck can bring these protein-tyrosine kinases to the Btk 
kinase (G. Cheng, Z.-S. Ye, and D. Baltimore, in prep.). 
Thus, SH3 binding can apparently serve to bring sub- 
strates to enzymes, to organize protein complexes at the 
cell membrane and probably elsewhere in the cell, and to 
regulate nzymatic activities. Given the nature of mol- 
ecules that contain SH3s, the purpose of these interac- 
tions must be to facilitate the transmission of signals 
through the cytoplasm and nucleus of the cell. 
The function of the Crk-SH3 interaction with Abl ap- 
pears to be, at least in part, to bring one or more tyrosines 
of Crk into the catalytic site of the Abl kinase domain. In 
vitro studies with the Abl kinase (Foulkes et al. 1985; 
Frackelton 1985), as well as its extensive phosphoryla- 
tion of bacterial proteins (Wang et al. 1982), led us to 
conclude previously that it was a kinase with very little 
intrinsic substrate specificity. We can now suggest hat 
this relative nonspecificity is a characteristic of the ac- 
tive site but that specificity can be mediated by interac- 
tions elsewhere in the molecule. Abl not only has its 
own SH2 and SH3 regions amino-terminal to the ki- 
nase--the SH2 having been implicated previously in 
bringing substrates to the kinase (Mayer and Baltimore, 
1994)--but i has the SH3-binding sites carboxy-terminal 
to the kinase, which capture substrates. In both cases, 
the substrates would be expected to dissociate from the 
enzyme relatively slowly compared with dissociation 
from enzymes that have substrate binding sites as inte- 
gral parts of their catalytic machinery. This has three 
consequences: The substrate will stay near the enzyme 
so that phosphorylation can predominate over dephos- 
phorylation by phosphatases; the enzyme will have a 
very low turnover number because the substrate will not 
dissociate easily; and other substrates can also be 
brought o the enzyme through secondary domain asso- 
ciations. Crk in particular has an SH2 domain that can 
interact with other proteins, potentially mediating for- 
mation of complex, multiprotein complexes. It has been 
shown previously that the SH2 domains can mediate 
complex formation, particularly on receptor protein-ty- 
rosine kinases, and we now must see SH3 as equally 
important in such interactions, especially because the 
Abl example shows us that one protein can have both an 
SH3 domain and an SH3-binding site. 
The limitation of turnover number caused by separat- 
ing the catalytic site from the substrate site has an im- 
portant implication for signal transduction pathways: A
signal will only be passed in a limited fashion, with rel- 
atively little amplification. By independent evolution of 
the substrate binding sites in transduction pathways, the 
extent of signal amplification can be controlled. A sim- 
ilar example is the Raf-Mek interaction, where Ra/ki- 
nase stably binds its substrate Mek kinase through its 
carboxyl catalytic domain (Crews and Erikson 1993; Van 
Aelst et al. 1993). 
In cells coexpressing HACrkI and c-Abl, HACrkI was 
phosphorylated by c-Abl as described; however, auto- 
phosphorylation f c-Abl in cells was not detected. This 
observation suggest that c-Abl may be activated without 
autophosphorylation, and the autophosphorylation, of- 
ten seen in transforming variants of Abl, may provide 
other signals, for example, recruiting SH2-containing 
signaling molecules. 
Crk structure and function 
The human crk proto-oncogene encodes two proteins 
through alternative splicing (Matsuda et al. 1992). In this 
study the association of Crk-I and Abl through the SH3 
interaction was demonstrated. Crk-II contains the Crk-I 
SH3 domain, making it likely that Crk-II will also asso- 
ciate with Abl in cells. Consistent with this possibility, 
the endogenous Crk-II proteins become phosphorylated 
on tyrosine in cells overexpressing transforming Abl lB. 
Mayer, unpubl.). Crk-II is the predominant form of Crk 
in most cells and differs in having a second SH3 domain 
of unknown specificity [Matsuda et al. 1992; Tanaka et 
al. 1993). Overexpression of human Crk-I leads to trans- 
formation of mammalian fibroblasts, whereas Crk-II is 
not transforming and therefore the second SH3 could 
serve to modulate the function of the first [Matsuda et al. 
19921. Microinjection of Crk-I into PC-12 cells induces 
neuronal differentiation, whereas Crk-II has a much 
weaker effect in PC-12 cells (Tanaka et al. 1993), again 
suggesting that the second SH3 is inhibitory to Crk func- 
tion. Thus, if Crk-I is a mediator of growth and differen- 
tiation events, Crk-II may have a more temperate activ- 
ity. 
Role of the Crk/Abi association in v-Crk 
transformation 
Avian v-Crk is composed of viral Gag protein fused to a 
Crk-I-like domain containing one SH2 domain and one 
SH3 domain (Mayer et al. 19881. Chicken embryo fibro- 
blasts infected with the avian retrovirus CT10 become 
rapidly transformed in tissue culture and induce tumors 
when injected into chickens (Mayer et al. 1988). Al- 
though v-Crk protein does not have a tyrosine kinase 
domain, cells transformed by CT10 virus display ele- 
vated tyrosine phosphorylation o  a number of proteins 
{Matsuda et al. 1990; Mayer and Hanafusa 1990a), sug- 
gesting that there is a tyrosine kinase involved in v-Crk 
transformation. Tyrosine kinase activity was found to 
associate with Crk {Mayer and Hanafusa 1990a), and 
790 GENES & DEVELOPMENT 
 Cold Spring Harbor Laboratory Press on April 23, 2020 - Published by genesdev.cshlp.orgDownloaded from 
Crk binds to Abl 
both Crk SH2 and SH3 domains were found to be re- 
quired for transformation (Mayer and Hanafusa 1990b). 
The demonstration of Crk and Abl association in this 
study indicates that the c-Abl tyrosine kinase is a Crk- 
associated tyrosine kinase and may play a critical role in 
Crk transformation. 
Binding of other adapter proteins to Abl 
Nck and Grb2 both interact with Abl in vitro. Nck was 
originally isolated from a melanoma expression eDNA 
library (Lehmann et al. 1990). It contains primarily three 
SH3 and one SH2 domains and is oncogenic. Overexpres- 
sion of Nck leads to transformation f mammalian fibro- 
blasts (Chou et al. 1992; Li et al. 1992). Nck is phospho- 
rylated on both tyrosine and serine and threonine in re- 
sponse to epidermal growth factor (EGF), platelet-derived 
growth factor {PDGF), and nerve growth factor (NGF) 
stimulation, in response to activation of T-cell receptor 
and membrane IgM receptor and in v-Src-transformed 
cells {Chou et al. 1992; Li et al. 1992; Meisenhelder and 
Hunter 1992; Park and Rhee 1992). It is a common target 
for many receptor and nonreceptor tyrosine kinases. Nck 
binds to tyrosine-phosphorylated EGF receptor or PDGF 
receptor through its SH2 domain (Li et al. 1992). Studies 
here suggest that Nck associates with c-Abl through one 
or more of its SH3 domains. This association may also 
lead to tyrosine phosphorylation of Nck and could be 
important for signal transduction as well as Nck trans- 
formation. 
Grb2 (Lowenstein et al. 1992), also known as ASH, 
Sere5, or Drk {Clark et al. 1992; Matuoka et al. 1992; 
Simon et al. 1993) is an SH2- and SH3-containing adapter 
that links activated protein-tyrosine kinase receptors to 
the Ras activator protein Sos. Consistent with our in 
vitro data, Pendergast et al. recently showed that both 
Grb2 SH3 domains can bind to c-Abl in vitro (Pendergast 
et al. 1993). The functional significance of this binding is 
uncertain because Grb2 is involved in other interactions 
with its SH3 domains, particularly with t e Ras activa- 
tor protein Sos. The Grb2 SH2, however, binds to a ty- 
rosine-phosphorylated site in Bcr-Abl that is critical for 
transformation (Pendergast e al. 1993), providing the op- 
portunity for a multipoint interaction among these pro- 
teins. 
The Crk, Nck, and Grb2 SH3-binding sites were 
mapped close to the nuclear localization signal. The as- 
sociation of these adapter molecules with Abl may block 
the translocation of Abl into the nucleus and, therefore, 
retain Abl in cytoplasm. Alternatively, the association of 
Crk with c-Abl may bring Crk into nucleus. Transloca- 
tion of proteins in cells is an important mechanism for 
transducing signals. 
c-Abl has one close relative, Arg, that might also be a 
target for binding by the adapters that bind to Abl. Arg is 
also a protein-tyrosine kinase with SH2, SH3, and a long 
carboxy-terminal extension {Kruh et al. 1986). The car- 
boxy-terminal portion of Arg is less homologous to c-Abl 
than the amino terminus, but the Crk, Nck, and Grb2 
SH3-binding sites identified in c-Abl are conserved, sug- 
gesting that these adapter molecules hould also bind 
Arg. 
Characteristics of SH3-binding sites 
The solution and crystal structure of the SH3 domains of 
spectrin, Src, Fyn, p85et, and PLC~ have been solved 
(Musacchio et al. 1992; Yu et al. 1992; Booker et al. 1993; 
Kohda et al. 1993; Koyama et al. 1993~ Noble et al. 1993). 
All of these SH3 domains are formed from five antipar- 
allel f~-strands. The perturbation of resonances by bound 
proline-rich peptides indicates that the binding site is a 
hydrophobic surface region of the SH3 domain that con- 
sists of aromatic residues flanked by two charged loops 
{Booker et al. 1993; Yu et al. 1992). 
Like the Abl-SH3-binding sites, the Crk, Nck, and 
Grb2 SH3-binding sites in c-Abl were mapped to proline- 
containing short stretches of amino acids. The CrkI- 
SH3-binding sites were proved to mediate the associa- 
tion of Crk-I and Abl in cells. The specificity of the SH3 
interactions i evident. However, is there any common 
structural motif in the SH3-binding sites that might fit 
into a conserved element of SH3 structure.~ An align- 
ment of the Abl, Crk, Nck, and Grb2 SH3-binding sites 
shows that two proline residues spaced by two noncon- 
served amino acids are conserved. The consensus PXXP 
was also observed among some other SH3-binding sites 
{Egan et al. 1993; Gout et al. 1993; Li et al. 1993; Liu et 
al. 1993; Rozakis-Adcock et al. 1993; G. Cheng, Z.-S. Ye, 
and D. Baltimore, in prep.; K. Alexandropoulos, unpubl.), 
suggesting that PXXP may serve as a scaffold for the SH3 
interaction. The amino acids around these two highly 
conserved proline residues might then determine SH3- 
binding specificity. For example, the nonconserved se- 
quences amino-terminal to the PXXP consensus, partic- 
ularly the critical proline at position 2 in the 3BP1 site, 
may play an important role for Abl-SH3-binding speci- 
ficity. The basic amino acid{s) carboxy-terminal to PXXP 
in the CrkI, Grb2, and Nck SH3-binding sites could play 
a similar role. 
Materials  and methods  
Cells and antibodies 
293T ceils {Pear et al. 1993) were grown in Dulbecco's modified 
Eagle medium {DMEM) containing 10% fetal bovine s rum, 100 
U/ml of penicillin, and 100 mg/ml of streptomycin. Mouse 
monoclonal antibody 12CA-5 (Berkeley Antibody Company), 
anti-Abl monoclonal antibody 24-21 (Oncogene Science), and 
goat anti-mouse IgG-HRPO and IgG2b-HRPO (Southern Bio- 
technology Associates, Inc} were used in this study. Abl-specific 
PEX4 antiserum was described previously {Konopka et al. 1984). 
The control monoclonal antibody used was an anti-RAG2 
monoclonal antibody (Spanopoulou etal. unpubl.). 
HACrkI-transformed cell lines were established by infecting 
NIH-3T3 cells with an HACrkI retrovirus. The helper-free 
HACrkI retrovirus was generated by transiently transfecting 
BOSC-23 cells with pGD/HACrkI as described {Pear t al. 
1993). NIH-3T3 cells [2x l0s) infected with 5x 10 s HACrkI ret- 
rovirus were transfered into 0.3% soft agar 2 days after infec- 
tion. Colonies were picked after 3 weeks. The transformed cells 
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were purified twice. Three independent transformed cell lines 
were analyzed. All of these cell lines expressed a high level of 
HACrkI. 
DNA constructs 
Plasmid DNAs were grown in E. coli DHSc~ and purified by 
CsC1 centrifugation (Ausubel et al. 1990). DNAs were cleaved 
with restriction endonucleases under conditions recommended 
by the manufacturer (Boehringer Mannheim Biochemicals). Re- 
striction fragments were purified by electrophoresis in low-gel- 
ling-temperature agarose gels (Ausubel et al. 1990). Ligations 
were performed according to the instructions of the manufac- 
turer of T4 DNA ligase (Boehringer Mannheim Biochemicals). 
For the two-hybrid screen, eDNA fragment encoding the car- 
boxy-terminal portion (amino acid 545-1149) of c-Abl (Ben-Ne- 
riah et al. 1986), excised from plasmid pBS/D20 {B. Mayer and 
D. Baltimore, unpubl.I by BamHI and NotI restriction enzyme 
digestion, was cloned in-frame into pEG202 vector with an 
EcoRI-BamHI linker. This plasmid was designated as pEG/ 
ablC'. 
For the in vitro SH3-binding assay, the eDNA fragment en- 
coding the carboxy-terminal portion (amino acid 545-1149) of 
oAbl was cloned in-frame into the pGEX-1ZT vector (modified 
pGEX-IKT IPharmacia) by inserting multiple restriction sites 
into EcoRI site of pGEX-IKT), pGEX-AblC'ASal and pGEX- 
AblC'AXho were constructed by subcloning the BamHI-SalI 
and BamHI-XhoI cDNA fragments from pBS/D20 in-frame into 
the pGEX-1ZT vector. A DNA fragment encoding AblC'-l l5 
and AblC'-56 was constructed with synthetic oligonucleotide- 
directed PCR of the c-abl cDNA under the conditions recom- 
mended by Perkin-Elmer Cetus. Pfu DNA polymerase (Strata- 
gene) was used for PCR. The PCR reaction was carried out for 15 
cycles at 95°C for 30 sec, 55°C for 1 min, and 72°C for 2 min. 
Oligonucleotides contain 22 bp of identical sequence for hybrid- 
ization and a BarnHI site (for the sense oligonucleotide) orXhoI 
site (for the anti-sense oligonucleotide) with four extra base 
pairs at the 5' end for stability and recutting efficiency. The 
PCR fragments were cloned in-frame into the BamHI-XhoI site 
of the pGEX-1ZT vector. The rest of DNA fragments encoding 
the peptides AB3-1 to AB3-3 were derived from the synthetic 
oligonucleotides. The oligonucleotides that were cloned into 
the BamHI-EcoRI site of the pGEX2T vector contained coding 
sequences plus 5'-GATCC-3' at the 5' end of the sense strand 
and 5'-AATT-3' at the 5' end of the anti-sense strand. The 5' 
end of the DNA fragments derived from these oligonucleotides 
were in-frame with the GST of pGEX2T and the 3' ends were 
out of frame, resulting in amino acid residues NSS at the car- 
boxyl terminus of the GST/peptide fusion proteins. The syn- 
thetic oligonucleotides were phosphorylated using T4 polynu- 
cleotide kinase under conditions recommended by the manu- 
facturer (New England Biolabs). The sense and anti-sense 
strands were annealed after phosphorylation by boiling for 2 
rain and then cooling down slowly to room temperature (about 
25°C). The DNA fragment was cloned into the pGEX-2T vector. 
The human Crk-I gene was cloned from HeLa cDNA by PCR 
using the 5' primer AAGGATAGGCGGCCGCCACCATGGT- 
TGGATACCCCTACGACGTCCCCGACTACGCCGGAGTT- 
ATGGCGGGCAACTTGGACTCG (where the underlined seg- 
ment encodes the HA epitope and the A TG indicates the natural 
start codon) and the 3' primer AAGGATAGGCGGCCGCAC- 
TCAGCTGAAGTCCTCATCGGGATTCTG. The PCR prod- 
uct was digested with NotI and cloned into the NotI site of 
pGDN, a derivative of the retroviral vector pGD (Daley et al. 
1990). Crk-I cDNA was confirmed by sequence analysis. The 
Crk-I cDNA in right orientation in pGDN vector was selected 
and used in studies. 
The pGD/abl mu~ was constructed by first subcloning BamHI 
(744, nucleotide number according to murine type IV c-abl) and 
XhoI (2285) from ABS-F (Mayer and Baltimore 1994) into pBS 
(Strategene). The PstI (1645) to PstI (1681) segment (encoding 
LQAPELPTKTRTC) was replaced by a linker encoding LQAE- 
FRTC. The BamHI and NarI fragment containing the mutation 
was cloned back to ABS-F and then the NotI fragment contain- 
ing the c-ablmu~-coding sequences was cloned into pGDN. The 
pGD/abl mu2 was constructed by replacing PLLPRK (596-601, 
amino acid number in type IV c-Abll into ID by oligo-directed 
PCR mutagenesis a described (Higuchi 1990). All of the muta- 
tions were confirmed by sequence analysis. 
The two-hybrid screen 
A genetic screen using the two-hybrid system was performed as
described (Zervos et al. 1993). The bait plasmid pEG/ablC' was 
transformed into yeast strain EGY48 with a reporter plasmid 
pSH18-34 that contains the LexAop-LEU2 reporter gene. This 
strain was transformed with the HeLa interaction library (Zer- 
vos et al. 1993). Yeast transformation was performed by the 
lithium acetate method (Ausubel et al. 1990) except hat 10% 
dimethylsulfoxide (DMSO) was included during 42°C heat 
shock. Ten million primary library transformants were ampli- 
fied, of which 5 million were screened. The candidate AblC' 
interacting clones were selected as meeting the following crite- 
ria: ( 1 ) They grew on Ura- His - Trp - Leu- -galactose plates; and 
(21 they turned blue on Ura-His -Trp-  X-gal-galactose plates 
but not on Ura-His -Trp-  X-gal-glucose plates. Plasmids from 
the candidate yeast strains were isolated (Hoffman and Winston 
1987), and the library plasmids were selected through KC8 cells. 
To test whether the library cDNAs truly encoded proteins that 
interacted specifically with AblC', the library plasmids were 
retransformed back into yeast with either EG202/AblC' or 
EG202. Sequencing of the interacting clones was performed us- 
ing Sequenase according to the manufacturer's directions (U.S. 
Biochemicall. 
Filter-binding assay 
To examine SH3 binding in vitro, a filter-binding assay was 
performed as described (Ren et al. 1993). GST/CrkI-SH3 was 
constructed by subcloning the EcoRI-XhoI eDNA fragment en- 
coding the c-Abl-interacting partial Crk-I protein from the 
pJG45 vector in-frame into pGEX-1ZT vector. The fusion pro- 
tein was purified using glutathione-agarose beads and biotiny- 
lated as described (Mayer et al. 1991). The GST/Abl-SH3, GST/ 
Src-SH3, GST/N-Src-SH3, and GST/Crk-SH3 probes were pre- 
pared as described (Cicchetti et al. 1992). The GST/Grb2, GST/ 
GrbN2, GST/Grb2C, and GST/Nck fusion proteins were 
generous gifts from J. Schlessinger (New York University). Bi- 
otinylation of these proteins was performed asdescribed (Mayer 
et al. 1991). 
Transfection 
Calcium phosphate transfection was performed as described 
(Pear et al. 1993). 293 T cells (1.5x 106) were seeded in 60-mm 
plastic cell culture plates 1 day before use. Each plate was 
treated with 0.5 or 1 ml of a DNA-calcium phosphate copre- 
cipitate containing 3 }ag each of the plasmid DNAs. After 18 hr 
of incubation at 37°C, the medium was replaced and incubation 
was continued for 24 hr. 
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Immunoprecipitation 
Cells (1 x l0 z) were washed once in ice-cold phosphate-buffered 
saline (PBS) containing 1 mM sodium orthovanadate and then 
lysed in 1 ml of ice-cold lysis buffer {50 mM HEPES at pH 7.4, 
150 mM NaC1, 10% glycerol, 1% Triton X-100, 1 mM EGTA, 1.5 
mM MgC12, 10 mM NaF, 1 mM sodium orthovanadate, 1 mM 
fleshly made phenylmethylsulfonyl fluoride, 10 ~g/ml of apro- 
tinin, 10 ~g/ml of leupeptin). The cell debris was removed by 
centrifugation at 14,000 rpm in Eppendorf centrifuge for 10 min 
at 4°C. The cell lysate was incubated with 5 lal of normal rabbit 
serum and 25 Ixl of protein G-plus/protein A-agarose (Oncogene 
Science) for 1 hr and then clarified by centrifugation at 14,000 
rpm in Eppendorf centrifuge for 2 rain. The clarified cell ysate 
was incubated with 5 ~g of the appropriate monoclonal anti- 
body or 5 ixl of the polyclonal antiserum at 4°C for 2-5 hr. The 
immunocomplexes were then collected after the addition of 25 
~1 of protein G-plus/protein A-agarose and incubation at 4°C 
for 30 rain. The pellets of agarose beads were washed three 
times with 1 ml of lysis buffer and then subjected to kinase 
reaction or immunoblotting. 
Kinase reaction 
The kinase reaction was carried out as described {Konopka et al. 
1984). The pellets of agarose beads obtained from immunopre- 
cipitation described above w re transferred to a fresh Eppendorf 
tube and washed twice with 1 ml of kinase buffer (20 mM 
HEPES at pH 7.4, 5 mM MgC12). The kinase reaction was carried 
out in 100 ~1 of kinase buffer containing 10 ~M ATP and 0.2 ~1 
of [~/-32P]ATP {7000 Ci/mmole) (ICN) at 30°C for 30 min. The 
pellets of agarose beads were washed with PBS twice. The bound 
proteins were eluted in Laemmli sample buffer at 95°C for 5 
rain, and then the phosphorylated proteins were analyzed by 
SDS-PAGE and autoradiography. 
Western blot analysis 
Cells were lysed as described above. The cell extracts or anti- 
HA immunoprecipitates were boiled in Laemmli sample buffer, 
electrophoretically separated on 10% SDS--polyacrylamide g ls 
and transferred to nitrocellulose. Filters were blocked in 10 mM 
Tris-HC1 at pH 8.0/0.9% NaC1/0.05 Tween 20 (TBST buffer) 
plus 2% nonfat dry milk. Filters were blotted with 1 ~g/ml of 
anti-HA antibody or anti-Abl monoclonal antibody in TBST/ 
milk buffer at room temperature for 2 hr. After wash in TBST, 
filters were incubated with anti-mouse IgG2b- or IgG-conju- 
gated horseradish peroxidase at a dilution of 1:2000 in TBST 
buffer at room temperature for 1 hr. Filters were then washed 
and developed with ECL (Amersham), as described by the man- 
ufacturer. 
Cell metabolic labeling and phosphoamino acid analysis 
After 48 hr of transfection, 293 cell monolayers were washed 
twice with phosphate-flee DMEM (GIBCO) and incubated in 
phosphate-free DMEM containing 10% dialyzed fetal bovine 
serum (GIBCO] for 2 hr. Cells were washed twice with phos- 
phate-flee DMEM again and incubated in phosphate-flee 
DMEM containing 10% dialyzed fetal bovine serum and 32P i
INEN, 1 mCi/ml per 60-ram dish) for 2 hr. The 32p-labeled cells 
were then washed once with ice-cold PBS and harvested, lysed, 
and immunoprecipitated with anti-HA antibody as described 
above. The immunoprecipitates w re separated electrophoreti- 
caUy in SDS-PAGE and detected by autoradiography. 
Phosphoamino acid analyses were performed as described 
(Naim and Greengard 1987; Li et al. 1992). Briefly, phosphory- 
lated protein bands were excised from dried SDS gels, rehy- 
drated in 50 mM NH4HCO3, minced, and boiled in 0.1% SDS/ 
5% [3-mercaptoethanol for 5 rain. The mixture was incubated at 
37°C with agitation overnight. The gel debris was removed by 
centrifugation. The supematants were mixed with 50 lag of BSA 
and precipitated in 15% trichloroacetic acid on ice for 90 rain. 
The precipitates were washed twice with cold acetone. The pro- 
tein was hydrolyzed in 6 N HC1 at 110°C for 1 hr. Hydrolysis was 
stopped by adding 1 ml of H20 and drying in a Speed-Vac. The 
sample was washed with H20, dried twice, and then dissolved 
in 5 ~xl of electrophoresis buffer {pH 1.9). Phosphoamino acid 
standards (2 ~g, phosphoserine, phosphothreonine, and phos- 
photyrosine) and 1 ~xl of 0.08% phenol red were added into the 
sample. The mixture was spotted on thin-layer chromatography 
{TLC), cellulose without fluorescent indicator (Kodak). The 
wetted TLC plate was run in pH 1.9 buffer at 500 V for 1 hr and 
then transferred to pH 3.5 buffer and run at 500 V for 1-1.5 hr. 
The TLC plate was then stained with 1% ninhydrine to show 
phosphoamino acid spots and exposed to X-ray film with an 
intensifying screen at - 70°C for 3 days. 
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